HDAC1 Inhibitors
Santa Cruz Biotechnology now offers a broad range of HDAC1 Inhibitors. Histone deacetylase proteins (HDACs) are a class of enzymes that remove acetyl groups (O=C-CH3) from an <ε>-N-acetyl lysine amino acid on a histone, allowing histones to wrap DNA more tightly. The deacetylation of histones is associated with transcriptional silencing. Histone deacetylase inhibitors (HDIs) have a long history of use in psychiatry and neurology as mood stabilizers and anti-epileptic. HDIs are studied as a treatment for neurodegenerative diseases and have a potential for cancer therapy. HDAC1 Inhibitors offered by Santa Cruz inhibit HDAC1 and, in some cases, other chromatin remodeling and transcription regulation related proteins. View detailed HDAC1 Inhibitor specifications, including HDAC1 Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
Items 21 to 27 of 27 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
M 344 | 251456-60-7 | sc-203124 sc-203124A | 1 mg 5 mg | $107.00 $316.00 | 8 | |
M 344 (CAS 251456-60-7) serves as an HDAC1 inhibitor, influencing cellular gene regulation processes. By interacting with HDAC1, it induces changes in epigenetic mechanisms, impacting cellular functions without broader implications. | ||||||
Pyroxamide | 382180-17-8 | sc-397030 | 5 mg | $79.00 | ||
Pyroxamide (CAS 382180-17-8) functions as an HDAC1 inhibitor, influencing cellular gene regulation processes. Through its interaction with HDAC1, it induces changes in epigenetic mechanisms, impacting cellular functions without broader implications. | ||||||
JNJ-26481585 | 875320-29-9 | sc-364515 sc-364515A | 5 mg 50 mg | $321.00 $1224.00 | ||
JNJ-26481585 (CAS 875320-29-9) serves as an HDAC1 inhibitor, influencing cellular gene regulation processes. By interacting with HDAC1, it induces changes in epigenetic mechanisms, impacting cellular functions without broader implications. | ||||||
PI3K/HDAC Inhibitor | 1339928-25-4 | sc-364584 sc-364584A | 5 mg 10 mg | $340.00 $462.00 | ||
PI3K/HDAC Inhibitor (CAS 1339928-25-4) acts as an inhibitor of HDAC1, influencing cellular gene regulation processes. Its interaction with HDAC1 leads to modifications in epigenetic mechanisms, affecting cellular functions without broader implications. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $61.00 $245.00 $1173.00 | ||
Chidamide targets HDAC1, resulting in histone hyperacetylation and influencing the transcription of genes involved in epigenetic regulation. | ||||||
PCI-24781 | 783355-60-2 | sc-364565 sc-364565A | 5 mg 50 mg | $182.00 $1330.00 | 1 | |
PCI-24781 (CAS 783355-60-2) functions as an HDAC1 inhibitor, impacting cellular gene regulation processes. Through its interaction with HDAC1, it induces changes in epigenetic mechanisms, influencing cellular functions without broader implications. | ||||||
Nexturastat A | 1403783-31-2 | sc-478176 | 1 mg | $330.00 | ||
Nexturastat A is a selective HDAC6 inhibitor that indirectly affects HDAC1 activity by modulating acetylation of cellular substrates. | ||||||